StockWatch
·

SIKA INTERPLANT SYSTEMS LTD.

BSE: 523606

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
45.36
+8.5%-35.0%
Expenditure
34.95
+11.7%-37.4%
Net Profit
8.48
+7.5%-18.3%
OPM %
19.49%
-5.77pp+1.10pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0019.5339.0558.5878.11Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Sika Interplant Q1 FY27: consolidated PAT -19% YoY as revenue slumps 37% on disruption

supply chain disruption · geopolitical tensions · margin expansion

ResultsQ1 FY2714 Aug 20263 minIndustrials & Infra
Latest
Quarterly Result14 Aug, 6:02 pm

Sika Interplant Q1 FY27: consolidated PAT -19% YoY as revenue slumps 37% on disruption

Sika Interplant Systems' consolidated revenue for Q1 FY27 came in at ₹42.86 Cr, down 36.98% year-on-year from ₹68.01 Cr in Q1 FY26, though up a modest 3.70% sequentially from ₹41.33 Cr in Q4 FY26. Consolidated PAT of ₹8.40 Cr fell a smaller 18.84% YoY (from ₹10.35 Cr) and rose 7.39% QoQ (from ₹7.82 Cr) — profit held up far better than the topline. There is no analyst/street consensus available for this micro-cap and no prior management guidance on record; neither our records nor a web search turned up a formal outlook to grade this print against, so vsStreet and vsGuidance are both unknown. The YoY profit resilience came from margin expansion: net profit margin rose to 18.52% of total income from 14.84% a year ago, and the EBITDA-level operating margin (OPM) improved to 19.48% from 18.38%, as standalone raw-material cost eased to 76.6% of sales versus 80.6% a year ago. Sequentially, though, OPM compressed sharply — from 25.21% in Q4 FY26 to 19.48% now — because material cost this quarter (76.6% of sales) ran well above Q4's unusually low 51.7%, suggesting Q4's margin strength was a favourable cost-mix quarter rather than a new baseline. Standalone PAT of ₹8.48 Cr tracks consolidated PAT of ₹8.40 Cr within 1%, so the two bases tell the same story. Management explicitly attributes the revenue shortfall to supply-chain disruptions from "prevailing geopolitical tensions," which delayed execution and delivery of customer orders and deferred revenue recognition — the identical note appears in both the standalone and consolidated filings. The company's own same-day disclosure additionally flags that these geopolitical tensions are expected to impact Q2 FY27 performance as well, so the deferred revenue is not guided to reverse immediately. Basic EPS (consolidated) was ₹3.96 versus ₹4.88 a year ago and ₹3.72 in Q4 FY26. The results are unaudited — limited review only, by statutory auditors Rao & Emmar — and were approved at the August 14, 2026 board meeting.

14 Aug 2026, 06:02 pm

Corporate Events

Board MeetingSIKA
2026
12Aug

Board Meeting

The 40th Annual General Meeting will be held to receive, con…

BSE Filing ↗
DividendSIKA
2026
5Aug

₹3.5 / share

BSE Filing ↗
Board MeetingSIKA
2026
11Feb

Board Meeting

Consider and approve Intimation of Board Meeting, Consider a…

BSE Filing ↗
Board MeetingSIKA
2025
5Nov

Board Meeting

Consider and approve Intimation of Board, Consider and appro…

BSE Filing ↗
Board MeetingSIKA
2025
12Aug

Board Meeting

consider and approve Unaudited Financial Statements (Standal…

BSE Filing ↗
Stock SplitSIKA
2025
17Mar

1:5

BSE Filing ↗
Board MeetingSIKA
2024
20May

Board Meeting

Consider and approve the Audited (standalone and consolidate…

BSE Filing ↗
Board MeetingSIKA
2024
13Feb

Board Meeting

Consider and approve unaudited financial statements (standal…

BSE Filing ↗
Board MeetingSIKA
2023
8Nov

Board Meeting

Consider and approve Unaudited Financial Statements (Standal…

BSE Filing ↗
Board MeetingSIKA
2023
9Aug

Board Meeting

Consider and approve Intimation of Board Meeting under regul…

BSE Filing ↗